Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial

In North America, no effective therapy has been available for patients with progressive metastatic colorectal cancer after front-line treatment with irinotecan, bolus fluorouracil (FU), and leucovorin (IFL). Patients with metastatic colorectal cancer who progressed after IFL therapy were randomly as...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical oncology Ročník 21; číslo 11; s. 2059
Hlavní autori:	Rothenberg, Mace L, Oza, Amit M, Bigelow, Robert H, Berlin, Jordan D, Marshall, John L, Ramanathan, Ramesh K, Hart, Lowell L, Gupta, Sunil, Garay, Carlos A, Burger, Brent G, Le Bail, Nathalie, Haller, Daniel G
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.06.2003
Predmet:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Camptothecin - administration & dosage Camptothecin - analogs & derivatives Colorectal Neoplasms - drug therapy Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Disease-Free Survival Female Fluorouracil - administration & dosage Humans Leucovorin - administration & dosage Male Middle Aged Neoplasm Metastasis Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Organoplatinum Compounds - therapeutic use Survival Rate United States - epidemiology
ISSN:	0732-183X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!